https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42664 Wed 31 Aug 2022 13:58:15 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43706 Wed 28 Sep 2022 10:16:06 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45183 Wed 26 Oct 2022 14:32:09 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45059 p = 0.02) to substantial (graduated tuning fork, К: 0.68, CI: 0.41–0.95, p < 0.01). The 10-site monofilament (К: 0.44–0.77) outperformed the 4-site test (К: 0.34–0.67) and the dampened tuning fork method (К: 0.41–0.49) showed lower intra-rater reliability compared to both conventional (К: 0.52–0.57) and graduated methods (К: 0.50–0.57). Conclusion: We support the current recommendations of using more than one test to screen and monitor progression of DPN. Four- and 10-site 10 g monofilament testing have similarly acceptable levels of reliability and the neurothesiometer is the most reliable method of assessing vibration perception function. Use of a graduated tuning fork was slightly more reliable than other methods of tuning fork application however all had substantial reliability. Years of clinical experience only marginally affected test reliability overall and due to subjective nature of the tests we suggest that testing should be performed regularly and repetitively.]]> Wed 26 Oct 2022 12:09:42 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30922 Wed 24 Nov 2021 15:50:56 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31015 Wed 17 Nov 2021 16:28:49 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40302 Wed 13 Mar 2024 08:50:00 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22591 Wed 11 Apr 2018 16:12:31 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7599 Wed 11 Apr 2018 16:00:15 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:11237 Wed 11 Apr 2018 15:26:19 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23650 Wed 11 Apr 2018 15:01:20 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25729 Wed 11 Apr 2018 12:05:09 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:11798 Wed 11 Apr 2018 11:56:09 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22838 Wed 11 Apr 2018 09:38:55 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31231 75% stenosis) in control group (80.77%). Conclusions: Our findings indicate that TPs are useful to assist in diagnosing PAD in clinical practice, however, results should be interpreted with caution due to the small probability of PAD being present with a negative test.]]> Wed 11 Apr 2018 09:21:58 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:11238 Wed 10 Jul 2019 15:29:28 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34482 Wed 06 Apr 2022 13:56:45 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54454 Tue 27 Feb 2024 13:59:20 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43135 Tue 13 Sep 2022 15:21:30 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34981 Tue 03 Sep 2019 18:19:17 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51322 Thu 31 Aug 2023 14:29:05 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45369 Thu 27 Oct 2022 15:02:10 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35451 Thu 13 Jan 2022 10:28:13 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46048 Thu 10 Nov 2022 10:14:32 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53211 Fri 17 Nov 2023 11:55:31 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39967 n = 39 of 111 participants or 35.1%) was associated with lower levels of self-perceived foot function (r = − 0.20, n = 107, p = 0.04). Conclusion: We found that community-based foot health care services that are culturally safe are utilised by Aboriginal and Torres Strait Islander Peoples not currently at high risk of foot complications. This supports the use of culturally safe foot care services to improve engagement with preventative foot care. Future research should continue to be driven by Aboriginal and Torres Strait Islander Peoples and investigate ways to implement additional screening measures and undertake prospective evaluation of the impact of such services on health related outcomes in these communities.]]> Fri 15 Jul 2022 10:18:34 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41807 Fri 12 Aug 2022 12:31:40 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51505 Fri 08 Sep 2023 11:56:03 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52997 Fri 03 Nov 2023 16:07:56 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37445 Fri 01 Apr 2022 09:23:55 AEDT ]]>